Fingerprint
Dive into the research topics of 'Treatment of advanced pancreatic carcinoma with 90Y-clivatuzumab tetraxetan: A phase I single-dose escalation trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Treatment of advanced pancreatic carcinoma with 90Y-clivatuzumab tetraxetan: A phase I single-dose escalation trial
Seza A. Gulec, Steven J. Cohen, Kenneth L. Pennington, Lionel S. Zuckier, Ralph J. Hauke, Heather Horne, William A. Wegener, Nick Teoh, David V. Gold, Robert M. Sharkey, David M. Goldenberg
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations